Specializing in Animal Health consulting and the execution of regulatory /development strategies and target animal studies (companion animal, production animal inc. poultry) to assure the full potential of new and current chemical and biologic entities within animal health.
Link your regulatory and development strategy to deliver on time approvals for vaccines (biologicals) or pharmaceuticals. Determine pathways for nutraceuticals, devices or other non regulatory pathways.
BioPharmaPotentials also develops and executes Proof of Concept, Proof of Value, Pivotal and Market Support studies- scope includes clinical efficacy, target animal safety, food safety, toxicology studies in all major species .
BioPharmaPotentials offers a broad range of CMC consulting and execution services.
Dr. Robb is an experienced leader building global teams that registered new veterinary products with annual sales> $500M. He received his B.S. in Animal Science and D.V.M. from Cornell. He practiced veterinary medicine in northern N.Y. before completing an M.S. in epidemiology and residency in Veterinary Nutrition at Penn. At Upjohn he served as Senior Director, Worldwide Animal Health Clinical Research and Product Development. Roles within Pfizer included Director, Senior Director, Executive Director,Global Project Development & Clinical Research and Head of Research for Embrex Inc. In 2008 he became VP, Research and Development at Boehringer Ingelheim Vetmedica. In 2013 at Ceva Animal Health he served VP Business Development and later took on roles as VP Pharmaceutical Research in the US.